These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15174726)

  • 41. Brief-duration rituximab/chemotherapy followed by maintenance rituximab in patients with diffuse large B-cell lymphoma who are poor candidates for R-CHOP chemotherapy: a phase II trial of the Sarah Cannon Oncology Research Consortium.
    Hainsworth JD; Flinn IW; Spigel DR; Clark BL; Griner PL; Vazquez ER; Doss HH; Shipley D; Franco LA; Burris HA; Greco FA;
    Clin Lymphoma Myeloma Leuk; 2010 Feb; 10(1):44-50. PubMed ID: 20223728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma.
    Mori M; Kitamura K; Masuda M; Hotta T; Miyazaki T; Miura AB; Mizoguchi H; Shibata A; Saito H; Matsuda T; Masaoka T; Harada M; Niho Y; Takaku F
    Int J Hematol; 2005 Apr; 81(3):246-54. PubMed ID: 15814336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
    Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
    Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Combination chemotherapy with mitoxantrone, etoposide, vindesine and prednisolone for relapsed or refractory malignant lymphoma: presence of cross-resistance to CHOP therapy].
    Takagi T; Sakai C; Oguro M
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):917-20. PubMed ID: 1605671
    [No Abstract]   [Full Text] [Related]  

  • 45. Non-Hodgkin's lymphoma trials in elderly look beyond CHOP.
    McNeil C
    J Natl Cancer Inst; 1998 Feb; 90(4):266-7. PubMed ID: 9486808
    [No Abstract]   [Full Text] [Related]  

  • 46. [A case of diffuse large cell lymphoma treated with combination chemotherapy of CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) and BEMP (bleomycin, etoposide, mitoxantrone, procarbazine) with complete remission].
    Itoh T; Sakata Y; Suzuki H; Sugimoto N; Sohma N; Kishibe T; Higuchi S; Seino Y
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):241-4. PubMed ID: 1371049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Results of treatment of the lymphoblastic and immunoblastic malignant lymphomas using the CHOP-bleo protocol (cyclophosphamide, doxorubicin, vincristine, bleomycin and prednisolone)].
    Płuzańska A; Kowalczyński M; Polkowska E; Stempczyńska J; Hyjek E
    Pol Arch Med Wewn; 1982; 68(1-2):55-64. PubMed ID: 6186997
    [No Abstract]   [Full Text] [Related]  

  • 48. Lymphomatoid granulomatosis with pulmonary and gastrointestinal involvement.
    Kappen JH; van Zaanen HC; Snelder SM; van Tilburg AJ; Rudolphus A
    BMJ Case Rep; 2017 Feb; 2017():. PubMed ID: 28167690
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of CHOP versus CIOP in good prognosis younger patients with histologically aggressive non-Hodgkin lymphoma.
    Burton C; Smith P; Vaughan-Hudson G; Qian W; Hoskin P; Cunningham D; Hancock B; Linch D
    Br J Haematol; 2005 Aug; 130(4):536-41. PubMed ID: 16098067
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rituximab CHOP for successful management of diffuse large B-cell lymphoma of the ovary.
    Ahbeddou N; Fetohi M; Khanoussi BE; Errihani H
    Arch Gynecol Obstet; 2011 May; 283(5):1173-4. PubMed ID: 20957380
    [No Abstract]   [Full Text] [Related]  

  • 51. Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone.
    Nakamae H; Tsumura K; Terada Y; Nakane T; Nakamae M; Ohta K; Yamane T; Hino M
    Cancer; 2005 Dec; 104(11):2492-8. PubMed ID: 16247790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Severe acute thrombocytopenia following rituximab therapy.
    Rosado M; Chao H; Rose M
    Leuk Lymphoma; 2007 Nov; 48(11):2239-40. PubMed ID: 17926181
    [No Abstract]   [Full Text] [Related]  

  • 53. Primary anaplastic large B-cell lymphoma in mandible: Long-term complete remission with R-CHOP regimen and involved field radiotherapy.
    Niscola P; Palombi M; Trawinska MM; Scaramucci L; Giovannini M; Perrotti AP; Fabritiis Pd; Fratoni S
    Oral Oncol; 2009 Sep; 45(9):e113. PubMed ID: 19457710
    [No Abstract]   [Full Text] [Related]  

  • 54. Peripheral blood smear in a case of intravascular lymphoma.
    Yoshida S; Nagafuji K
    Eur J Haematol; 2008 Oct; 81(4):327. PubMed ID: 18637028
    [No Abstract]   [Full Text] [Related]  

  • 55. Final analysis of the UKLG LY02 trial comparing 6-8 cycles of CHOP with 3 cycles of CHOP followed by a BEAM autograft in patients <65 years with poor prognosis histologically aggressive NHL.
    Linch DC; Yung L; Smith P; Maclennan K; Jack A; Hancock B; Cunningham D; Hoskin P; Qian W; Holte H; Boesen AM; Grigg A; Browett P; Trneny M
    Br J Haematol; 2010 Apr; 149(2):237-43. PubMed ID: 20201949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A rare case of small bowel intussusception.
    Murino A; Despott EJ; Hansmann A; Heath P; Fraser C
    Endoscopy; 2012; 44 Suppl 2 UCTN():E157-8. PubMed ID: 22622719
    [No Abstract]   [Full Text] [Related]  

  • 57. A rapidly growing lung mass with air crescent formation.
    Lota HK; Dusmet M; Steele K; Wells AU; Nicholson AG; Hansell DM; Renzoni EA
    Thorax; 2013 Apr; 68(4):394-5. PubMed ID: 22504890
    [No Abstract]   [Full Text] [Related]  

  • 58. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
    Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU
    Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma.
    Katsuya H; Suzumiya J; Sasaki H; Ishitsuka K; Shibata T; Takamatsu Y; Tamura K
    Leuk Lymphoma; 2009 Nov; 50(11):1818-23. PubMed ID: 19863173
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
    Fridrik MA; Jaeger U; Petzer A; Willenbacher W; Keil F; Lang A; Andel J; Burgstaller S; Krieger O; Oberaigner W; Sihorsch K; Greil R
    Eur J Cancer; 2016 May; 58():112-21. PubMed ID: 26990931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.